Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafness

Hearing Research(2020)10.1016/j.heares.2020.107955Source: DataRank Database

Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafness is a research paper published in Hearing Research (2020). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 1.54)OA: greenTopics (58)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Omar Akil ORCID,Hainan Lang ORCID,Patricia A. Leake

Live enrichment

PubMed:32331858 PMC:PMC7660539 OpenAlex:https://openalex.org/W3014407835

National Institutes of Health

Grant: 5R01DC01306

NIH

Grant: R01DC012058

NIH

Grant: P50DC00422

NIH

Grant: R56DC012058

NIDCD NIH HHS

Grant: P50 DC000422

NIDCD NIH HHS

Grant: K18 DC018517

National Institutes of Health

Grant: 3R01DC012058-04S1

Auditory Nerve Degeneration and Repair

National Institutes of Health

Grant: 2R56DC012058-06A1

Auditory Nerve Degeneration and Repair

National Institutes of Health

Grant: 3P50DC000422-20S1

Experimental and Clinical Studies of Presbyacusis

FWCI

1.54

Citation Percentile

0.9%

Influential Citations

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7660539

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660539

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7660539

publisherhttps://api.elsevier.com/content/article/PII:S0378595519304563?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0378595519304563?httpAccept=text/plain

Fields of Study

Hearing, Cochlea, Tinnitus, GeneticsHearing Loss and RehabilitationConducting polymers and applicationsMedicine0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsDeafnessHumansNeuronsSpiral GanglionGenetic TherapyBrain-Derived Neurotrophic FactorNeurotrophin 3

Keywords

Spiral ganglionCochleaNeurotrophic factorsHearing lossNeurotrophinMedicineCochlear implantNeuroscienceAudiologyPsychologyInternal medicineBrain-derived neurotrophic factor (BDNF)Profound Hearing LossCochlear Implant (Ci)Cochlear Spiral Ganglion NeuronsAdeno-associated Viral Vectors (Aav)Neurotrophin Gene TherapyClinical SciencesMedical PhysiologyBioengineeringAllied Health and Rehabilitation ScienceDeafnessAdeno-associated viral vectorsBrain-derived neurotrophic factorNeurotrophin 3Health SciencesGeneticsAnimalsHumansPediatricNeuronsAssistive TechnologyBiomedical and Clinical SciencesPreventionRehabilitationNeurosciencesEarGene TherapyGenetic TherapyOtorhinolaryngologyNeurologicalBiological psychologyBiotechnology

Sustainable Development Goals

SDG 0: Good health and well-being

Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafness

FAIR Checklist

Authors (3)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)